Publication | Closed Access

Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics

Antimicrobial Susceptibilityβ-Lactam AntibioticsAntimicrobial StewardshipAntibioticsMedicineHealth SciencesConvulsive LiabilityNew CarbapenemPharmacotherapyAntimicrobial ChemotherapyAntimicrobial PharmacokineticsAntibacterial AgentPharmacologyClinical MicrobiologyAntimicrobial ResistanceDrug Resistance